282 related articles for article (PubMed ID: 21063076)
1. An experience of oseltamivir phosphate (tamiflu™) in a pediatric patient with chronic idiopathic thrombocytopenic purpura: a case report.
Alioglu B; Tasar A; Ozen C; Selver B; Dallar Y
Pathophysiol Haemost Thromb; 2010; 37(2-4):55-8. PubMed ID: 21063076
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic thrombocytopenic purpura triggered by influenza A virus subtype H1N1 infection.
Koh YR; Hwang SH; Chang CL; Lee EY; Son HC; Kim HH
Transfus Apher Sci; 2012 Feb; 46(1):25-8. PubMed ID: 22094185
[TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
4. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
[TBL] [Abstract][Full Text] [Related]
5. 2009 Influenza A H1N1 infections: delays in starting treatment with oseltamivir were associated with a more severe disease.
Launes C; García-García JJ; Jordán I; Martínez-Planas A; Selva L; Muñoz-Almagro C
Pediatr Infect Dis J; 2011 Jul; 30(7):622-5. PubMed ID: 21200359
[TBL] [Abstract][Full Text] [Related]
6. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
Nakamura K; Schwartz BS; Lindegårdh N; Keh C; Guglielmo BJ
Clin Infect Dis; 2010 Apr; 50(7):e47-9. PubMed ID: 20192728
[TBL] [Abstract][Full Text] [Related]
7. Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial.
Watanabe A; Chang SC; Kim MJ; Chu DW; Ohashi Y;
Clin Infect Dis; 2010 Nov; 51(10):1167-75. PubMed ID: 20936975
[TBL] [Abstract][Full Text] [Related]
8. Immune thrombocytopenic purpura in patients with hepatitis C virus infection.
Nakajima H; Takagi H; Yamazaki Y; Toyoda M; Takezawa J; Nagamine T; Mori M
Hepatogastroenterology; 2005; 52(64):1197-200. PubMed ID: 16001660
[TBL] [Abstract][Full Text] [Related]
9. Acute immune thrombocytopenic purpura in an adolescent with 2009 novel H1N1 influenza A virus infection.
Lee CY; Wu MC; Chen PY; Chou TY; Chan YJ
J Chin Med Assoc; 2011 Sep; 74(9):425-7. PubMed ID: 21962253
[TBL] [Abstract][Full Text] [Related]
10. Aseptic meningitis in a child due to 2009 pandemic influenza A (H1N1) infection.
Ozdemir H; Karbuz A; Ciftçi E; Ince E; Doğru U
Turk J Pediatr; 2011; 53(1):91-3. PubMed ID: 21534347
[TBL] [Abstract][Full Text] [Related]
11. Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.
Petersen E; Keld DB; Ellermann-Eriksen S; Gubbels S; Ilkjær S; Jensen-Fangel S; Lindskov C
Scand J Infect Dis; 2011 Jul; 43(6-7):495-503. PubMed ID: 21309638
[TBL] [Abstract][Full Text] [Related]
12. The use of antiviral agents for the management of severe influenza.
Smith JR; Ariano RE; Toovey S
Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416
[TBL] [Abstract][Full Text] [Related]
13. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A.
Rodríguez A; Díaz E; Martín-Loeches I; Sandiumenge A; Canadell L; Díaz JJ; Figueira JC; Marques A; Alvarez-Lerma F; Vallés J; Baladín B; García-López F; Suberviola B; Zaragoza R; Trefler S; Bonastre J; Blanquer J; Rello J;
J Antimicrob Chemother; 2011 May; 66(5):1140-9. PubMed ID: 21385717
[TBL] [Abstract][Full Text] [Related]
14. Influenza A/H1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure.
Watcharananan SP; Suwatanapongched T; Wacharawanichkul P; Chantratitaya W; Mavichak V; Mossad SB
Transpl Infect Dis; 2010 Apr; 12(2):127-31. PubMed ID: 20102550
[TBL] [Abstract][Full Text] [Related]
15. Using oseltamivir (Tamiflu) as a first line treatment for seasonal or pandemic flu.
Greener M
Nurs Times; 2009 Sep 1-7; 105(34):22. PubMed ID: 19788111
[No Abstract] [Full Text] [Related]
16. Relapse of idiopathic thrombocytopenic purpura caused by influenza A virus infection: a case report.
Kaneko H; Ohkawara Y; Nomura K; Horiike S; Taniwaki M
J Infect Chemother; 2004 Dec; 10(6):364-6. PubMed ID: 15614463
[TBL] [Abstract][Full Text] [Related]
17. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
[TBL] [Abstract][Full Text] [Related]
18. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.
Baz M; Abed Y; Papenburg J; Bouhy X; Hamelin ME; Boivin G
N Engl J Med; 2009 Dec; 361(23):2296-7. PubMed ID: 19907034
[No Abstract] [Full Text] [Related]
19. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.
Esposito S; Molteni CG; Colombo C; Daleno C; Daccò V; Lackenby A; Principi N
J Clin Virol; 2010 May; 48(1):62-5. PubMed ID: 20335065
[TBL] [Abstract][Full Text] [Related]
20. Mixtures of oseltamivir-sensitive and -resistant pandemic influenza A/H1N1/2009 viruses in immunocompromised hospitalized children.
Suhaila M; Tang JW; Lee HK; Lin C; Tambyah PA; Yap HK; Quak SH; Koay ES
Pediatr Infect Dis J; 2011 Jul; 30(7):625-7. PubMed ID: 21206398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
